{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:21Z","timestamp":1792785021149,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["P50 AG05681"],"award-info":[{"award-number":["P50 AG05681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["P01 AG03991"],"award-info":[{"award-number":["P01 AG03991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["P01 AG026276"],"award-info":[{"award-number":["P01 AG026276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["P50 AG005136"],"award-info":[{"award-number":["P50 AG005136"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["U01 AG16976"],"award-info":[{"award-number":["U01 AG16976"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["P30 NS057105"],"award-info":[{"award-number":["P30 NS057105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["T32 NS007205"],"award-info":[{"award-number":["T32 NS007205"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["P41 RR000954"],"award-info":[{"award-number":["P41 RR000954"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Charles and Joanne Knight Alzheimer Research Initiative"},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000888","name":"W.M. Keck Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000888","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institutes of Health\/National Institute on Aging","award":["R01AG031278"],"award-info":[{"award-number":["R01AG031278"]}],"id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institutes of Health\/National Institute on Aging","award":["K23-AG031861"],"award-info":[{"award-number":["K23-AG031861"]}],"id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institutes of Health\/National Institute on Aging","award":["P01 AG019724"],"award-info":[{"award-number":["P01 AG019724"]}],"id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institutes of Health\/National Institute on Aging","award":["P50 AG023501"],"award-info":[{"award-number":["P50 AG023501"]}],"id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"name":"University Of California, San Francisco Alzheimer's Disease Research Centers","award":["P50 AG023501"],"award-info":[{"award-number":["P50 AG023501"]}],"id":[{"id":"https:\/\/ror.org\/043mz5j54","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008539","name":"CurePSP","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008539","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Association for Frontotemporal Dementias"},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"crossref","award":["UL1 RR024992"],"award-info":[{"award-number":["UL1 RR024992"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eli Lilly"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca"},{"name":"American Neurological Association meeting Baltimore, Praque","id":[{"id":"https:\/\/ror.org\/04h7e4549","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.biopsych.2010.08.025","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T04:36:07Z","timestamp":1288326967000},"page":"903-912","source":"Crossref","is-referenced-by-count":463,"title":["YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease"],"prefix":"10.1016","volume":"68","author":[{"given":"Rebecca","family":"Craig-Schapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Mintun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine R.","family":"Peskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Galasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Reid","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2010.08.025_bib1","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/WNL.38.11.1688","article-title":"A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: Prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques","volume":"38","author":"Davies","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2010.08.025_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","article-title":"Pathologic correlates of nondemented aging, mild cognitive impairment, and early stage Alzheimer's disease","volume":"17","author":"Morris","year":"2001","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.biopsych.2010.08.025_bib3","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/00005072-199812000-00009","article-title":"Neuropathological and neuropsychological changes in \u201cnormal\u201d aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals","volume":"57","author":"Hulette","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2008.10.003","article-title":"Biomarkers of Alzheimer's disease","volume":"35","author":"Craig-Schapiro","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2010.08.025_bib5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature08538","article-title":"Multimodal techniques for diagnosis and prognosis of Alzheimer's disease","volume":"461","author":"Perrin","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2010.08.025_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of Alzheimer's disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2010.08.025_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib8","doi-asserted-by":"crossref","first-page":"25803","DOI":"10.1016\/S0021-9258(19)74461-5","article-title":"Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family","volume":"268","author":"Hakala","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2010.08.025_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-3-27","article-title":"Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD","volume":"3","author":"Colton","year":"2006","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.biopsych.2010.08.025_bib10","first-page":"172","article-title":"Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer","volume":"53","author":"Johansen","year":"2006","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.biopsych.2010.08.025_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2217\/fon.09.66","article-title":"Plasma YKL-40: A potential new cancer biomarker?","volume":"5","author":"Johansen","year":"2009","journal-title":"Future Oncol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis","volume":"133","author":"Comabella","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2010.08.025_bib13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2010.08.025_bib14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.8191290","article-title":"An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants","volume":"264","author":"Suzuki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2010.08.025_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/01.wnl.0000228231.26111.6e","article-title":"Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI","volume":"67","author":"Storandt","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2010.08.025_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and CSF Ab42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2010.08.025_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/Ab42 ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib20","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2010.08.025_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of The NINDS-SPSP International Workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2010.08.025_bib22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/prca.200600999","article-title":"Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease","volume":"1","author":"Hu","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.biopsych.2010.08.025_bib23","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1074\/mcp.M500207-MCP200","article-title":"Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid","volume":"4","author":"Hu","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.biopsych.2010.08.025_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","article-title":"CSF tau\/Ab42 ratio for increased risk of mild cognitive impairment: A follow-up study","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2010.08.025_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancent Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archneurol.2009.55","article-title":"Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type","volume":"66","author":"Snider","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/neuro.05.007.2009","article-title":"Neurons in the white matter of the adult human neocortex","volume":"3","author":"Suarez-Sola","year":"2009","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.biopsych.2010.08.025_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jocn.2006.11.014","article-title":"Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage","volume":"15","author":"Kacira","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.biopsych.2010.08.025_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2353\/ajpath.2008.080045","article-title":"YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor","volume":"173","author":"Bonneh-Barkay","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib30","first-page":"598","article-title":"YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis","volume":"9","author":"Ostergaard","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib31","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0002-9440(10)64336-2","article-title":"Induction of pathogenic sets of genes in macrophages and neurons in neuroaids","volume":"162","author":"Roberts","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","article-title":"In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases","volume":"7","author":"Bonneh-Barkay","year":"2010","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.biopsych.2010.08.025_bib33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid beta-amyloid(1\u201342) in Alzheimer's disease: Differences between early- and late-onset Alzheimer's disease and stability during the course of disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JAD-2007-12307","article-title":"Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years","volume":"12","author":"Zetterberg","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2010.08.025_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.biopsych.2010.08.025_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease\u2014a double-edged sword","volume":"35","author":"Wyss-Coray","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2010.08.025_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2010.08.025_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2006.11.017","article-title":"Inflammatory processes in Alzheimer's disease","volume":"184","author":"Heneka","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib39","doi-asserted-by":"crossref","first-page":"41213","DOI":"10.1074\/jbc.M510146200","article-title":"Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes","volume":"280","author":"Recklies","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2010.08.025_bib40","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.181.7.5167","article-title":"YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages","volume":"181","author":"Letuve","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib41","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1006\/bbrc.2001.5253","article-title":"YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes","volume":"285","author":"De Ceuninck","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopsych.2010.08.025_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/bj20020075","article-title":"The chitinase 3-like protein human cartilage glycoprotein. 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways","volume":"365","author":"Recklies","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.biopsych.2010.08.025_bib43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/bj20040099","article-title":"The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha","volume":"380","author":"Ling","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.biopsych.2010.08.025_bib44","doi-asserted-by":"crossref","first-page":"21082","DOI":"10.1074\/jbc.M601153200","article-title":"The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation","volume":"281","author":"Bigg","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2010.08.025_bib45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/excr.1999.4511","article-title":"Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells","volume":"250","author":"Malinda","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.biopsych.2010.08.025_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-4827(03)00069-7","article-title":"gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells","volume":"287","author":"Nishikawa","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.biopsych.2010.08.025_bib47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1084\/jem.20081271","article-title":"Role of breast regression protein 39 (BRP-39)\/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis","volume":"206","author":"Lee","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.biopsych.2010.08.025_bib48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2010.08.025_bib50","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased b-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer's disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310008905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310008905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T16:08:21Z","timestamp":1636733301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322310008905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0006322310008905"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2010.08.025","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}